Stockholders' Equity (Tables)

3 Months Ended

Nov. 30, 2021

Share-based Payment Arrangement [Abstract]

Schedule of Recognized Stock-based Compensation Expense

The Company recognized stock-based compensation expense within selling, general and administrative expense as follows (in millions):

	Three months ended
	November 30, 2021		November 30, 2020
Restricted stock units	$	32	$	32
Employee stock purchase plan	3		2
Total	$	35	$	34

Schedule of Share-based Compensation Information

The following represents the stock-based compensation information as of the period indicated (in millions):

	November 30, 2021
Unrecognized stock-based compensation expense—restricted stock units	$	67
Remaining weighted-average period for restricted stock units expense	1.5 years

Schedule of Common Stock Outstanding

The following represents the common stock outstanding for the periods indicated:

	Three months ended
	November 30, 2021	November 30, 2020
Common stock outstanding:
Beginning balances	144,496,077	150,330,358
Vesting of restricted stock	2,425,472	2,217,082
Purchases of treasury stock under employee stock plans	(690,555)	(601,406)
Treasury shares purchased(1)	(2,064,985)	(1,474,464)
Ending balances	144,166,009	150,471,570

(1)In July 2021, the Board of Directors approved an authorization for the repurchase of up to $1.0 billion of the Company’s common stock (“the 2022 Share Repurchase Program”). As of November 30, 2021, 2.8 million shares had been repurchased for $169 million and $831 million remains available under the 2022 Share Repurchase Program.